close

Cannabinoids in multiple sclerosis CAMS) study: safety and efficacy data for 12 months follow up

Book Cover: Cannabinoids in multiple sclerosis CAMS) study: safety and efficacy data for 12 months follow up

Cannabis and its component cannabinoids (particularly tetrahydrocannabinol (D9-THC), believed to be the major active cannabinoid) have been claimed anecdotally to improve symptoms related to multiple sclerosis (MS), although until recently there has been little scientific evidence of effect. There is also experimental evidence that cannabinoids may have a neuroprotective action.

Published:
Genres:
Redaksi

The author Redaksi

Tim pengelola media dan data Rumah Cemara

Leave a Response

This site uses Akismet to reduce spam. Learn how your comment data is processed.